{"SPADE_N_05029": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0077289 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0077289_A1", "Patent Type": "Patent Application", "Publication Date": "2003-4-24", "Family Info": "CN1309417C,CN1503628A,WO2002064057A2,WO2002064057A3", "Patent Title": "Use of cell-penetrating peptides to generate antitumor immunity.", "Abstract": "The present invention is directed to methods and compositions for enhancing an immune response in an animal to a disease by administering an immune effector cell comprising a cell penetrating peptide associated with an antigen for the disease. In a specific embodiment, the immune effector cell is a dendritic cell comprising a cell penetrating peptide associated with an antitumor antigen for cancer immunotherapy."}], "Sequence Information": {"SPADE ID": "SPADE_N_05029", "Sequence": "SVYDFFVWL", "Sequence Length": 9, "Peptide Name": "Sequence 2 from Patent US 20030077289", "Source": "Human", "Biological Activity": ["Antitumor"], "Frequent Amino Acids": "FVD", "Absent Amino Acids": "ACEGHIKMNOPQRTU", "Basic Residues": 0, "Acidic Residues": 1, "Hydrophobic Residues": 7, "Polar Residues": 4, "Positive Residues": 0, "Negative Residues": 1, "Mass": 1175.33, "PI": 4.05, "Net Charge": -1, "Hydrophobicity": 1.26, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08156", "Similarity": 1.0, "Sequence": "MKLLLLTLAALLLVSQLTPGDAQKCWNLHGKCRHRCSRKESVY"}, {"SPADE_ID": "SPADE_UN_00997", "Similarity": 1.0, "Sequence": "VYDFFVWL"}, {"SPADE_ID": "SPADE_UN_06915", "Similarity": 1.0, "Sequence": "FVWLLIIFLSLFLFEITVGGRYTTPWCVRDIDCPKEKCKHPFKPRCLTHSCVCRLWGSQDVI"}]}}}